Determination of 14 steroid hormones in amniotic fluid (AF) 1 its usefulness in the antenatal diagnosis of 21-hydroxylasc deficiency.
In 63 AF of normal pregnancies (14-20 wks), AF levels of testosterone (TI, androstendone ( A41 were higher in males, while those of pre nenolone (Preg), 170Hgregncnolone (1 70H-preg), 170H-progesterone bHP), DHA, A54txkostenediol and 1 B estradiol were l g h t l y but significantly higher in females. There was no sex difference in AF levels of preg. sulfate (PS) or DHA sulfate, progesterone, estrone, cortisol and cortisone. Amon 4 pregnancies at risk for congenital adrenal hyperplasia (CAH) due to ~l-fydroxylase defect, antenatal diagnwis (Dgs) of CAH was made in 1, on the high AF levels of OHP and confirmed at birth. We then investigated whether estimating AF levels of other steroids could consolidate the Dgs.
In the AF of the affected girl, T, dk were also drastically elevated, PS, r g and 170Hpreg were just above normal limits (NL), while the other amones were normal. Similarly T, A4 and OHP were drastically elevated in the peripheral blood at birth. In contrast none of the estimations in the cord blood would have made the dgs with certainty, although OHP was above normal.
In conclusion the simultaneous measurement of T, A4 and OHP may prove to be safer for the definitive antenatal dgs of CAH than single hormone analysis. Addenbrookes Hospital, Cambridge. England An XX male with 21-hydroxylase deficiency. The patient is the second child of healthy unrelated parents.his older brother is normal. At birth the genitalia were ambiguous; the phallus was adequate in size but there was chordee and peri= neal hypospadias. The labio-scrota1 folds were fuscd. Gonads were palpable in both groins. The karyotype (blood and skin) was nor= ma1 female XX. Biopsy of both gonads showed immature testes with no ovarian elements; the XX genotype was confirmed in gonadal ti5 sue. Laparotomy showed normal male and absent female internal ge nitalia. Hypospadias repair was undertaken and the child was r e ! red in the male sex. At 6 years he was noted to be viri1ising.He had shown rapid growth and weight gain and development of pubic and axillary hair. Plasma steroids by RIb and urinary steroidsby GLC/MS indicated partial 21-hydroxylase deficiency. There was normal suppression with exogenous steroids and a selenocholesterol scan showed bilateral adrenal hyperplasia.He is maintainedon hydro-cortisone and continues to make a good progress at the age of 9.This patient has an apparently unique combination of genetic endocrine defects unlikely to be due to chance. Subjects affected by pituitary dwarfism and treated with Growth Hormone (GH) preparations extracted according to the Raben proce= dure have a high incidence of anti-GH antibodies. These antibodies were detected in 7 out of 22 patients treated with the GRORM (Se= rono) clinical preparation. Two of them showed a significantly impaired growth rate (19 and 28% less than the mean value in the other 20 patients). Their sera bound labelled GH with a high affix nity (Kaff 0.66 and 1.16 x IO-~M). The binding capacity was 0.32 and 0.75 mgGH/l, respectively. We fractionated the GRORM prepara= tion by gel filtration (Sephadex G-100) and tested the two sera with different protein peaks. The fraction having a m.w.of 80,000, a Kav of 0.20 and an immunoreactivity equal to 84% of the GH mono= mer was bound more and with a higher association rate. This frac= tion is 12-24% of the GRORM preparation and it probably consists of GH aggregates. The present data suggests a major role of the GH aggregates in eliciting anti-GH antibodies production in these patients.
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